A detailed history of Voya Investment Management LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Voya Investment Management LLC holds 11,667 shares of URGN stock, worth $124,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,667
Previous 11,618 0.42%
Holding current value
$124,136
Previous $194,000 23.71%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$12.7 - $17.92 $622 - $878
49 Added 0.42%
11,667 $148,000
Q2 2024

Dec 03, 2024

SELL
$12.72 - $19.2 $623 - $940
-49 Reduced 0.42%
11,618 $194,000
Q2 2024

Aug 14, 2024

BUY
$12.72 - $19.2 $147,780 - $223,065
11,618 New
11,618 $194,000
Q4 2023

Feb 14, 2024

BUY
$10.87 - $15.93 $120,439 - $176,504
11,080 New
11,080 $166,000
Q4 2021

Feb 14, 2022

SELL
$9.03 - $19.13 $1.34 Million - $2.84 Million
-148,439 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$14.31 - $18.39 $172,893 - $222,187
-12,082 Reduced 7.53%
148,439 $2.5 Million
Q2 2021

Aug 16, 2021

SELL
$15.2 - $20.94 $88,631 - $122,101
-5,831 Reduced 3.51%
160,521 $2.45 Million
Q1 2021

May 17, 2021

SELL
$17.99 - $26.96 $3.27 Million - $4.89 Million
-181,515 Reduced 52.18%
166,352 $3.24 Million
Q4 2020

Feb 16, 2021

SELL
$17.54 - $25.43 $543,810 - $788,431
-31,004 Reduced 8.18%
347,867 $6.27 Million
Q3 2020

Nov 16, 2020

BUY
$18.81 - $26.42 $1.69 Million - $2.38 Million
89,982 Added 31.15%
378,871 $7.31 Million
Q2 2020

Aug 14, 2020

BUY
$16.5 - $29.7 $1.67 Million - $3.01 Million
101,470 Added 54.14%
288,889 $7.55 Million
Q1 2020

May 15, 2020

BUY
$13.68 - $34.6 $921,717 - $2.33 Million
67,377 Added 56.13%
187,419 $3.34 Million
Q4 2019

Feb 14, 2020

BUY
$21.11 - $34.86 $2.53 Million - $4.18 Million
120,042 New
120,042 $4.01 Million
Q3 2019

Nov 14, 2019

SELL
$23.83 - $36.44 $159,398 - $243,747
-6,689 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$32.75 - $40.35 $219,064 - $269,901
6,689 New
6,689 $240,000

Others Institutions Holding URGN

About UroGen Pharma Ltd.


  • Ticker URGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 22,740,500
  • Market Cap $242M
  • Description
  • UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...
More about URGN
Track This Portfolio

Track Voya Investment Management LLC Portfolio

Follow Voya Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.